Chugai Pharmaceutical News

Chugai Pharmaceutical: Supplementary Materials for Consolidated Financial Statements for the Third Quarter of the Fiscal Year 2024.12 (IFRS)

Oct 25 16:00

Chugai Pharmaceutical: Consolidated financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] supplementary materials

Oct 25 16:00

Chugai Pharmaceutical: Notice regarding revisions to the dividend forecast for the fiscal year ending 2024/12

Oct 25 16:00

Chugai Pharmaceutical: Notice of Revisions to Dividend Forecast for Fiscal Year Ending December 31, 2024

Oct 25 16:00

Chugai Pharmaceutical: Notice of Revisions to Financial Forecasts

Oct 25 16:00

Chugai Pharmaceutical: Notice regarding revisions to earnings forecasts

Oct 25 16:00

Chugai Pharmaceutical: CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the third quarter of the fiscal year 2024)

Oct 25 16:00

Chugai Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [IFRS] (consolidated)

Oct 25 16:00

Chugai Pharmaceutical: F. Hoffmann-La Roche Announces Third Quarter Sales 2024

Oct 23 13:00

Chugai Pharmaceutical: Sales results for the 3rd quarter of 2024 for F Hoffman La Roche

Oct 23 13:00

Chugai Pharmaceutical: Confirmatory letter.

Jul 26 14:02

Chugai Pharmaceutical: Interim report - 114th Period (01/01/2024 - 12/31/2024)

Jul 26 14:01

Chugai Pharmaceutical: Confirmation letter

Jul 26 13:35

Chugai Pharmaceutical: (Correction) Partial Correction to Consolidated Financial Statements (IFRS) for the 2023 Fiscal Year (Unaudited)

Jul 26 13:30

Chugai Pharmaceutical: (Correction/Correction of numerical data) Correction of some parts of the "Fiscal Year ending December 2023 Consolidated Financial Statements [IFRS] (Consolidated)"

Jul 26 13:30

Chugai Pharmaceutical: Corrected Financial Report - 113th Term (2023/01/01 - 2023/12/31)

Jul 26 13:30

Chugai Pharmaceutical: Interim financial results (IFRS) for the second quarter of December 2024. (Consolidated)

Jul 25 15:00

Chugai Pharmaceutical: Supplemental materials for the interim consolidated financial statements for the second quarter of fiscal year 2024. (IFRS 12)

Jul 25 15:00

Chugai Pharmaceutical: Provisional linked financial statements (IFRS) (unaudited) (Q2 of fiscal year 2024)

Jul 25 15:00

Chugai Pharmaceutical: Supplementary information for the consolidated financial statements (IFRS) for the second quarter (interim) of the period ending in December 2024.

Jul 25 15:00